The Requirement of CD80, CD86, and ICAM-1 on the Ability of Adjuvant Formulations to Potentiate Antibody Reponses to a Plasmodium falciparum Blood-Stage Vaccine

Por Hui, George, Hashimoto, Caryn
Publicado em 2007

Interleukin 6 has Differential Influence on the Ability of Adjuvant Formulations to Potentiate Antibody Reponses to a Plasmodium falciparum Blood-Stage Vaccine

Por Hui, George, Hashimoto, Caryn
Publicado em 2007

Adjuvant Formulations Possess Differing Efficacy in the Potentiation of Antibody and Cell Mediated Responses to a Human Malaria Vaccine under Selective Immune Genes Knockout Enviro...

Por Hui, George S., Hashimoto, Caryn N.
Publicado em 2008

Medical School Hotline: Training the Next Generation of Minority Health Scientists: A STEP-UP in the Right Direction

Por Hui, George S, Pusic, Kae M
Publicado em 2011

Pathways for Potentiation of Immunogenicity during Adjuvant-Assisted Immunizations with Plasmodium falciparum Major Merozoite Surface Protein 1

Por Hui, George S. N., Hashimoto, Caryn N.
Publicado em 1998

Biological Activities of Anti-Merozoite Surface Protein-1 Antibodies Induced by Adjuvant-Assisted Immunizations in Mice with Different Immune Gene Knockouts

Por Hui, George, Choe, Dan, Hashimoto, Caryn
Publicado em 2008

Plasmodium falciparum: Immunization with MSP1-42 Induced Non-inhibitory Antibodies that have No Blocking Activities but Enhanced the Potency of Inhibitory Anti-MSP1-42 Antibodies

Por Nagata, Mark, Wong, Teri, Clements, David, Hui, George
Publicado em 2006

Antibody and T Cell Responses in Reciprocal Prime-Boost Studies with Full-Length and Truncated Merozoite Surface Protein 1–42 Vaccines

Por Pusic, Kae, Clements, Danielle, Kobuch, Sophie, Hui, George
Publicado em 2013

Medical School Hotline: Pacific Center for Emerging Infectious Diseases Research

Por Yanagihara, Richard, Nerurkar, Vivek R, Hui, George, Jacobs, Gwen A
Publicado no Hawaii J Med Public Health (2017)

Blood Stage Merozoite Surface Protein Conjugated to Nanoparticles Induce Potent Parasite Inhibitory Antibodies

Por Pusic, Kae, Xu, Hengyi, Stridiron, Andrew, Aguilar, Zoraida, Wang, Andrew, Hui, George
Publicado em 2011

T Cell Epitope Regions of the P. falciparum MSP1-33 Critically Influence Immune Responses and In Vitro Efficacy of MSP1-42 Vaccines

Por Pusic, Kae M., Hashimoto, Caryn N., Lehrer, Axel, Aniya, Charmaine, Clements, David E., Hui, George S.
Publicado em 2011

Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine

Por Pusic, Kae, Aguilar, Zoraida, McLoughlin, Jaclyn, Kobuch, Sophie, Xu, Hong, Tsang, Mazie, Wang, Andrew, Hui, George
Publicado em 2013

Characterization of Conserved T- and B-Cell Epitopes in Plasmodium falciparum Major Merozoite Surface Protein 1

Por Parra, Marcela, Hui, George, Johnson, Armead H., Berzofsky, Jay A., Roberts, Theodore, Quakyi, Isabella A., Taylor, Diane W.
Publicado em 2000

In Vivo Expression and Immunological Studies of the 42-Kilodalton Carboxyl-Terminal Processing Fragment of Plasmodium falciparum Merozoite Surface Protein 1 in the Baculovirus-Silk...

Por Pang, Alan L. Y., Hashimoto, Caryn N., Tam, Leslie Q., Meng, Z. Q., Hui, George S. N., Ho, Walter K. K.
Publicado em 2002

Efficacy of Two Alternate Vaccines Based on Plasmodium falciparum Merozoite Surface Protein 1 in an Aotus Challenge Trial

Por Stowers, Anthony W., Cioce, Vittoria, Shimp, Richard L., Lawson, Mark, Hui, George, Muratova, Olga, Kaslow, David C., Robinson, Robin, Long, Carole A., Miller, Louis H.
Publicado em 2001